Je n'avais pas vu passer cette note de cadrage #HAS de 2025

💸 "Malgré une diminution de sa prescription depuis 10 ans, le montant remboursé par l’Assurance maladie pour la VS en 2023 représente 12 millions €"
🔻"Les PNDS sur le lupus et sur l’artérite à cellules
géantes ne mentionnent plus la VS"

New study in #Blood VTH:
We show that the AcuStar HIT-IgG (Werfen) CLIA is a reliable & fast ⏱️ diagnostic tool for #HIT with strong agreement vs anti-PFA/H ELISA (Hyphen) & SRA
@davidmsmadja.bsky.social @hopitalpompidou.bsky.social
@bloodjournals.hematology.org
ashpublications.org/bloodvth/art...

ASH and ‪@isth.org‬ just released updated clinical practice guidelines for the treatment of pediatric venous thromboembolism (VTE)!

This update reflects the latest research to support evidence-based care for children with #VTE.

Learn more: doi.org/10.1182/bloo...

🎥: www.youtube.com/watc...

Veysel Grok and and team share an update on platelets!

Inherited platelet disorders are characterized by thrombocytopenia, platelet dysfunction, or both, leading to recurrent bleeding and diagnostic challenges.
Read about it here: www.rpthjournal.org/article/S247...

Settle in for a great weekend read!

What do we know about lipid signatures in immunothrombosis? 🦠

Tamam Bakchoul and Madhumita Chatterjee fill us in on lessons learned from VITT.
Check out their Commentary: www.rpthjournal.org/article/S247...

🩸In acquired hemophilia A, the first year post-remission is the danger zone.

New study from Wolfgang Miesbach shows that initial FVIII <1 IU/dL and failure to reach complete remission = higher relapse risk.
Monitor patients closely!
🔗 www.rpthjournal.org/article/S247...

#worldhemophiliaday

Male and female patients with VWD face unique sexual health challenges.
While 3.5% of men report restrictions, nearly 10% of women do—most due to heavy menstrual bleeding.
It's time to make sexual health a routine discussion.
🔗